Showing results (251-260 of 609) with videos related to
Sort By:
Pageof 61
Archives of Internal Medicine|June 16, 2004
Medical illness and the risk of suicide in the elderlyDavid N Juurlink, Nathan Herrmann, John P Szalai, et al.The Cochrane Database of Systematic Reviews|April 22, 2015
Latrepirdine for Alzheimer's diseaseSarah Chau, Nathan Herrmann, Myuri T Ruthirakuhan, et al.Journal of Clinical Psychopharmacology|June 27, 2003
Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjectsJennifer R Glass, Beth A Sproule, Nathan Herrmann, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 26, 2010
Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysisYekta Dowlati, Nathan Herrmann, Walter L Swardfager, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 11, 2007
Epidemiology of social phobia in later lifeJohn Cairney, Laura McCabe, Scott Veldhuizen, et al.Einstein (Sao Paulo, Brazil)|May 12, 2025
Effects of Tai Chi and Qigong intervention on anxiety and stress in diabetic and hypertensive Brazilian patients: a randomized controlled trialLaís Renata Almeida Cezário Santos, Anderson Taíra, Rosana de Fátima Possobon, et al.The Cochrane Database of Systematic Reviews|February 18, 2011
Antidepressants for agitation and psychosis in dementiaDallas P Seitz, Nikesh Adunuri, Sudeep S Gill, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 30, 2011
At-fault motor vehicle crash risk in elderly patients treated with antidepressantsMark J Rapoport, Brandon Zagorski, Dallas Seitz, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|September 28, 2011
Determining the impact of dementia on antidepressant treatment response in older adultsCorinne E Fischer, Tom A Schweizer, Jemcy Joy, et al.Expert Opinion on Drug Safety|October 17, 2022
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's diseaseNathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.Pageof 61